Stage distribution and performance status of newly diagnosed patients in a UK regional mesothelioma centreKHAN, Shahul; EVISON, Matthew; ALALOUL, Mohamed et al.Lung cancer. 2014, Vol 85, Num 1, pp 99-100, issn 0169-5002, 2 p.Article

Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 TrialsSONPAVDE, Guru; POND, Gregory R; KO, Yoo-Joung et al.European urology. 2013, Vol 63, Num 4, pp 717-723, issn 0302-2838, 7 p.Article

Hypofractionated radiotherapy for elderly or younger low-performance status glioblastoma patients: Outcome and prognostic factorsCHANG, Eric L; WON YL; ALLEN, Pamela K et al.International journal of radiation oncology, biology, physics. 2003, Vol 56, Num 2, pp 519-528, issn 0360-3016, 10 p.Conference Paper

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trialTABERNERO, Josep; VAN CUTSEM, Eric; CHEVALIER, Soazig et al.European journal of cancer (1990). 2014, Vol 50, Num 2, pp 320-331, issn 0959-8049, 12 p.Conference Paper

Prospective study of transarterial infusion of docetaxel and cisplatin to treat non-small-cell lung cancer in patients contraindicated for standard chemotherapyNAKANISHI, Masanori; YOSHIDA, Yoshimasa; NATAZUKA, Toshiki et al.Lung cancer. 2012, Vol 77, Num 2, pp 353-358, issn 0169-5002, 6 p.Article

Predicting end-of-life in patients with an exacerbation of COPD by routine clinical assessmentMURPHY, Stephen A; MYDIN, Helmy Haja; FATAH, Saman et al.Respiratory medicine. 2010, Vol 104, Num 11, pp 1668-1674, issn 0954-6111, 7 p.Article

Interconversion of three measures of performance status: An empirical analysisMA, Clement; BANDUKWALA, Shazeen; BURMAN, Debika et al.European journal of cancer (1990). 2010, Vol 46, Num 18, pp 3175-3183, issn 0959-8049, 9 p.Article

Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer Results of a phase II study in elderly patients or patients with impaired performance statusABBREDERIS, K; LORENZEN, S; FISCHER VON WEIKERSTHAL, L et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 1, pp 84-90, issn 1040-8428, 7 p.Article

Performance status 1 predicts psychological response in female, but not male, ambulatory cancer patientsTANIGUCHI, Koji; AKECHI, Tatsuo; SUZUKI, Shimako et al.Supportive care in cancer. 2003, Vol 11, Num 7, pp 465-471, issn 0941-4355, 7 p.Article

Single-agent versus combination chemotherapy as first-line treatment for patients with advanced non-small cell lung cancer and performance status 2: A literature-based meta-analysis of randomized studiesMÖRTH, Charlott; VALACHIS, Antonis.Lung cancer. 2014, Vol 84, Num 3, pp 209-214, issn 0169-5002, 6 p.Article

Prognostic factors and clinical features in patients with leptominengeal metastases from breast cancer: a single center experienceMEATTINI, Icro; LIVI, Lorenzo; NORI, Jacopo et al.Journal of chemotherapy (Testo stampato). 2012, Vol 24, Num 5, pp 279-284, issn 1120-009X, 6 p.Article

Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: External validation in a phase III trial comparing vinflunine with docetaxelDI MAIO, Massimo; KRZAKOWSKI, Maciej; FOUGERAY, Ronan et al.Lung cancer. 2012, Vol 77, Num 1, pp 116-120, issn 0169-5002, 5 p.Article

The safety and efficacy of EGFR TKIs monotherapy versus single-agent chemotherapy using third-generation cytotoxics as the first-line treatment for patients with advanced non-small cell lung cancer and poor performance statusSHAN LIU; DEQIANG WANG; BO CHEN et al.Lung cancer. 2011, Vol 73, Num 2, pp 203-210, issn 0169-5002, 8 p.Article

EFFECT OF IMMOBILIZATION AND PERFORMANCE STATUS ON INTRAFRACTION MOTION FOR STEREOTACTIC LUNG RADIOTHERAPY: ANALYSIS OF 133 PATIENTSWINNIE LI; PURDIE, Thomas G; BISSONNETTE, Jean-Pierre et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 5, pp 1568-1575, issn 0360-3016, 8 p.Article

Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experienceHOTTA, Katsuyuki; KIURA, Katsuyuki; TANIMOTO, Mitsune et al.Lung cancer. 2010, Vol 70, Num 3, pp 308-312, issn 0169-5002, 5 p.Article

Prognostic factors for limited-stage small cell lung cancer: A study of 284 patientsJUN CHEN; RUOXIANG JIANG; GARCES, Yolanda I et al.Lung cancer. 2010, Vol 67, Num 2, pp 221-226, issn 0169-5002, 6 p.Article

Discrepancies in performance status scores as determined by cancer patients and oncologists : are they influenced by depression?HONG JIN JEON; SHIM, Eun-Jung; SHIN, Yong-Wook et al.General hospital psychiatry. 2007, Vol 29, Num 6, pp 555-561, issn 0163-8343, 7 p.Article

Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancerHENSING, Thomas A; SCHELL, Michael J; LEE, Ji-Hyun et al.Lung cancer. 2005, Vol 47, Num 2, pp 253-259, issn 0169-5002, 7 p.Article

Factors associated with adherence to chemotherapy guidelines in patients with non-small cell lung cancerSALLOUM, Ramzi G; SMITH, Thomas J; JENSEN, Gail A et al.Lung cancer. 2012, Vol 75, Num 2, pp 255-260, issn 0169-5002, 6 p.Article

Survival among non-small cell lung cancer patients with poor performance status after first line chemotherapySALLOUM, Ramzi G; SMITH, Thomas J; JENSEN, Gail A et al.Lung cancer. 2012, Vol 77, Num 3, pp 545-549, issn 0169-5002, 5 p.Article

Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selectionHATA, Akito; KATAKAMI, Nobuyuki; NISHIYAMA, Akihiro et al.Lung cancer. 2011, Vol 74, Num 2, pp 268-273, issn 0169-5002, 6 p.Article

Prognostic Factors in Small Cell Lung Cancer: A New Prognostic Index in Korean PatientsHONG, Soojung; BYOUNG CHUL CHO; HYE JIN CHOI et al.Oncology. 2010, Vol 79, Num 3-4, pp 293-300, issn 0030-2414, 8 p.Article

Serum vascular endothelial growth factor is related to systemic oxidative stress in patients with lung cancerKATSABEKI-KATSAFLI, A; KERENIDI, T; KOSTIKAS, K et al.Lung cancer. 2008, Vol 60, Num 2, pp 271-276, issn 0169-5002, 6 p.Article

Physical performance evaluation of older cancer patients : A preliminary studyOVERCASH, Janine A; RIVERA, Henry R.Critical reviews in oncology/hematology. 2008, Vol 68, Num 3, pp 233-241, issn 1040-8428, 9 p.Article

Poor performance status is associated with early death in patients with pulmonary tuberculosisDE VALLIERE, S; BARKER, R. D.Transactions of the Royal Society of Tropical Medicine and Hygiene. 2006, Vol 100, Num 7, pp 681-686, issn 0035-9203, 6 p.Article